Mitotic adaptations shape acquired resistance and vulnerabilities to KIF18A inhibition in cancer
Preprint
Abstract
KIF18A inhibition selectively kills cancer cells by inducing chromosome alignment defects that activate a spindle assembly checkpoint (SAC)-dependent mitotic arrest. The mechanisms by which initially sensitive cancer cells acquire resistance to KIF18A inhibitors (KIF18Ai), the vulnerabilities of resistant cells, and the initial genetic determinants of KIF18Ai sensitivity remain poorly understood. Using orthogonal CRISPR–Cas9 screening and long-term drug adaptation approaches, we identify two convergent resistance mechanisms. Resistant cells either partially override the SAC, permitting mitotic exit despite chromosome misalignment, or adapt spindle microtubule dynamics to restore chromosome alignment in the absence of KIF18A. Both strategies sustain mitotic progression without inducing KIF18Ai dependence or increasing sensitivity to other mitotic perturbations. In contrast, reduced activity of the mitotic exit regulators PP2A or APC/C enhances KIF18Ai sensitivity. Accordingly, Mps1 inhibitor-driven APC/C mutations enhance responsiveness to KIF18A inhibition. In conclusion, resistance to KIF18A inhibition emerges rapidly, yet distinct genetic contexts create exploitable vulnerabilities to KIF18Ai.Keywords
Funding Information
- European Research Council (101043815)
- European Research Council (855158)
- Hrvatska Zaklada za Znanost (PCH-2022-10-9344)
- Hrvatska Zaklada za Znanost (IP-2024-05-5336)
- Regional Development Fund (KK.01.1.1.04.0057)
- Regional Development Fund (PK.1.1.10.0004)
This publication has 47 references indexed in Scilit:
- Super-Resolution Imaging of Mitotic Spindle Microtubules Using STED Microscopy2024
- Length-dependent poleward flux of sister kinetochore fibers promotes chromosome alignmentCell Reports, 2022
- Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate DependenciesCell Reports, 2019
- Interactions between N-terminal Modules in MPS1 Enable Spindle Checkpoint SilencingCell Reports, 2019
- Defining a Cancer Dependency MapCell, 2017
- Antimitotic drugs in the treatment of cancerCancer Chemotherapy and Pharmacology, 2015
- Targeting the Mitotic Checkpoint to Kill Tumor CellsDiscover Oncology, 2010
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle DamageCancer Cell, 2010
- The Kinesin-8 Kif18A Dampens Microtubule Plus-End DynamicsCurrent Biology, 2010
- The Human Kinesin Kif18A Is a Motile Microtubule Depolymerase Essential for Chromosome CongressionCurrent Biology, 2007